We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Amneal Pharmaceuticals Holding Co | NYSE:AMRX | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 5.87 | 0 | 01:00:00 |
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) today announced that members of management will participate at the following upcoming investor conferences:
To access a live webcast of the presentation, visit Amneal’s Investor Relations Web site at https://investors.amneal.com.
The Goldman Sachs Conference webcast can also be accessed at the following URL:https://event.webcasts.com/starthere.jsp?ei=1249194&tp_key=29cffed06b&tp_special=8.
The Raymond James Conference webcast can also be accessed at the following URL:http://wsw.com/webcast/rj115/amrx/.
An archived version will be available approximately one hour after the live presentation and can be accessed at the same location for 90 days.
About Amneal
Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater, NJ, is an integrated pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company has approximately 6,000 employees in its operations in North America, Asia, and Europe, working together to bring high-quality medicines to patients primarily within the United States.
Amneal is one of the largest and fastest growing generic pharmaceutical manufacturers in the United States, with an expanding portfolio of generic products to include complex dosage forms in a broad range of therapeutic areas. The Company also markets a portfolio of branded pharmaceutical products through its Specialty segment focused principally on central nervous system disorders and parasitic infections. For more information, visit www.amneal.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190606005063/en/
Mark Donohue(908) 409-6718
1 Year Amneal Pharmaceuticals Chart |
1 Month Amneal Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions